| P50 | author | Xin-Wu Cui | Q83382075 |
| | Michael Bachmann Nielsen | Q58104217 |
| | Dirk Andre Clevert | Q58879758 |
| | Odd Helge Gilja | Q56655099 |
| P2093 | author name string | Masatoshi Kudo | |
| | Andre Ignee | |
| | Christoph F Dietrich | |
| | Fabio Piscaglia | |
| | Paul S Sidhu | |
| | Yi Dong | |
| | Michel Claudon | |
| | Yuko Kono | |
| | Dagmar Schreiber-Dietrich | |
| | Fuminori Moriyasu | |
| | Ioan Sporea | |
| | Peter N Burns | |
| | Maria Franca Meloni | |
| | Nathalie Lassau | |
| | Claude B Sirlin | |
| | Vito Cantisani | |
| | Tae Kyoung Kim | |
| | Mirko D'Onofrio | |
| | Stephanie R Wilson | |
| | David Cosgrove | |
| | Adrian Saftoiu | |
| | Andrej Lyshchik | |
| | Richard G Barr | |
| | Hyun-Jung Jang | |
| | Maria Stanczak | |
| | Michalakis Averkiou | |
| | Jean-Michel Correas | |
| | Christian Jenssen | |
| | Maria C Chammas | |
| | Alexandar Vezeridis | |
| | Byung Choi | |
| | Christian Nolsøe | |
| | Fabrizio Calliada | |
| | Hans-Peter Weskott | |
| | JohnR Eisenbrey | |
| | Juergen Karl Willmann | |
| | Maija Radzina | |
| | Sue Westerway | |
| | Teresa Fontanilla | |
| P2860 | cites work | Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008 | Q80689480 |
| | Endoscopic retrograde cholangiography with contrast ultrasonography | Q81795475 |
| | Minimum training recommendations for the practice of medical ultrasound | Q82690742 |
| | Three-dimensional contrast-enhanced endoscopic ultrasound for the diagnosis of autoimmune pancreatitis | Q82798708 |
| | Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study | Q82912935 |
| | Dynamic contrast enhanced ultrasound assessment of the vascular effects of novel therapeutics in early stage trials | Q83389173 |
| | Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound | Q83824793 |
| | Intraductally applied contrast-enhanced ultrasound (IA-CEUS) for improved visualization of obstructive diseases of the salivary glands, primary results | Q84628359 |
| | Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy | Q84871546 |
| | Technical aspects of contrast-enhanced ultrasound (CEUS) examinations: tips and tricks | Q85321986 |
| | The EFSUMB website, a guide for better understanding | Q87314018 |
| | [How to perform contrast enhanced ultrasound] | Q87875296 |
| | Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification—Preliminary Results 1 | Q22255600 |
| | US-guided peripheral vascular interventions, comments on the EFSUMB guidelines | Q26744841 |
| | Benign liver tumors in pediatric patients - Review with emphasis on imaging features. | Q26801185 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part I. General Aspects (long Version) | Q26829889 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part I. General Aspects (Short Version) | Q26860813 |
| | Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS | Q26997111 |
| | An Introduction to the EFSUMB Guidelines on Interventional Ultrasound (INVUS) | Q27004182 |
| | Contrast-enhanced endoscopic ultrasound | Q27692610 |
| | Ultrasound contrast agents | Q28077669 |
| | EFSUMB guidelines 2015 on interventional ultrasound | Q28082404 |
| | Update on the safety and efficacy of commercial ultrasound contrast agents in cardiac applications | Q28085632 |
| | Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS | Q28278903 |
| | Imaging biomarker roadmap for cancer studies | Q30242020 |
| | Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma | Q30388235 |
| | Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI | Q30433022 |
| | Three-dimensional subharmonic ultrasound imaging in vitro and in vivo | Q30453926 |
| | Voiding urosonography with ultrasound contrast agents for the diagnosis of vesicoureteric reflux in children. I. Procedure | Q30496352 |
| | Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. | Q30542673 |
| | Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR). | Q31168771 |
| | The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. | Q34211494 |
| | Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study | Q34465123 |
| | The role of contrast-enhanced ultrasound in the detection of focal liver leasions. | Q34495408 |
| | American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of Hepatocellular Carcinoma: a pictorial essay | Q36318697 |
| | Voiding urosonography with US contrast agents for the diagnosis of vesicoureteric reflux in children. II. Comparison with radiological examinations | Q36885916 |
| | Quantitative Volumetric Perfusion Mapping of the Microvasculature Using Contrast Ultrasound | Q37294756 |
| | Pitfalls and artefacts using contrast enhanced ultrasound | Q37851450 |
| | Usefulness of contrast enhanced ultrasound guidance in percutaneous biopsies of liver tumors. | Q37897140 |
| | An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion | Q38030471 |
| | Contrast-enhanced ultrasound-guided radiofrequency ablation of renal tumors | Q38059597 |
| | EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. | Q38096207 |
| | Artifacts and pitfalls in contrast-enhanced ultrasound of the liver. | Q38183273 |
| | Contrast enhanced ultrasound in pediatric patients: a real challenge | Q38260057 |
| | WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 5. Prostate. | Q38938645 |
| | WFUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography: Part 4. Thyroid | Q38939604 |
| | WFUMB Position Paper. Learning Gastrointestinal Ultrasound: Theory and Practice | Q38981043 |
| | Integration of Contrast-enhanced US into a Multimodality Approach to Imaging of Nodules in a Cirrhotic Liver: How I Do It. | Q39093650 |
| | Contrast-enhanced ultrasound (CEUS): an excellent tool in the follow-up of small renal masses treated with cryoablation | Q39096998 |
| | Thyroid Ultrasound: State of the Art Part 1 - Thyroid Ultrasound reporting and Diffuse Thyroid Diseases. | Q39127596 |
| | Thyroid Ultrasound: State of the Art. Part 2 - Focal Thyroid Lesions. | Q39261001 |
| | 3D analysis is superior to 2D analysis for contrast-enhanced ultrasound in revealing vascularity in focal liver lesions - A retrospective analysis of 83 cases | Q39729149 |
| | Effect of observer experience in the differentiation between benign and malignant liver tumors after ultrasound contrast agent injection | Q39913302 |
| | Dose-dependent artifact in the far wall of the carotid artery at dynamic contrast-enhanced US. | Q40011369 |
| | Anal fistula: Levovist-enhanced endoanal ultrasound: a pilot study | Q40601381 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III - Abdominal Treatment Procedures (Short Version). | Q40793806 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part III - Abdominal Treatment Procedures (Long Version). | Q40870340 |
| | Correction of Non-Linear Propagation Artifact in Contrast-Enhanced Ultrasound Imaging of Carotid Arteries: Methods and in Vitro Evaluation. | Q40984174 |
| | Intracavitary contrast-enhanced ultrasound in abscess drainage--feasibility and clinical value. | Q41112269 |
| | Contrast-enhanced (endoscopic) ultrasound and endoscopic ultrasound elastography in gastrointestinal stromal tumors | Q41760791 |
| | Contrast-enhanced endoscopic ultrasound: Why do we need it? A foreword | Q42335253 |
| | Pseudoenhancement within the local ablation zone of hepatic tumors due to a nonlinear artifact on contrast-enhanced ultrasound. | Q43155053 |
| | Metastatic renal cell carcinoma treated with sunitinib: early evaluation of treatment response using dynamic contrast-enhanced ultrasonography | Q43166821 |
| | Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results | Q43539282 |
| | Prolonged heterogeneous liver enhancement on contrast-enhanced ultrasound | Q43770990 |
| | Quantitative contrast enhanced ultrasound of the liver for time intensity curves-Reliability and potential sources of errors | Q44001691 |
| | Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study. | Q44560343 |
| | Ultrasound contrast media in paediatric patients: is it an off-label use? Regulatory requirements and radiologist's liability | Q45828276 |
| | Diagnosis of Hepatocellular Carcinoma with Non-Invasive Imaging: a Plea for Worldwide Adoption of Standard and Precise Terminology for Describing Enhancement Criteria | Q46110377 |
| | Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). | Q46209737 |
| | Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies | Q46627418 |
| | Effects of Needle and Catheter Size on Commercially Available Ultrasound Contrast Agents | Q47361150 |
| | EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound | Q56959939 |
| | EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound | Q56959945 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part V | Q56964245 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part IV - EUS-guided Interventions: General aspects and EUS-guided sampling (Long Version) | Q56965629 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II. Diagnostic Ultrasound-Guided Interventional Procedures (Long Version) | Q56967567 |
| | Ultrasound assessment of vascularization of the thickened terminal ileum wall in Crohn's disease patients using a low-mechanical index real-time scanning technique with a second generation ultrasound contrast agent | Q56995480 |
| | The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations | Q56997483 |
| | Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer: a prospective, blinded, patient-by-patient analysis | Q57778635 |
| | A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures | Q74148537 |
| | [3D real time contrast enhanced ultrasonography,a new technique] | Q77774437 |
| | Focal liver lesions: sinusoidal phase of CEUS | Q79794566 |
| | Guidelines for the use of contrast agents in ultrasound. January 2004 | Q80428190 |
| | Feasibility and Usefulness of Intra-Cavitary Contrast-Enhanced Ultrasound in Percutaneous Nephrostomy. | Q51304236 |
| | Counter-propagating wave interaction for contrast-enhanced ultrasound imaging. | Q51312368 |
| | Early evaluation of targeted drugs using dynamic contrast-enhanced ultrasonography for personalized medicine. | Q51541831 |
| | Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial). | Q51654537 |
| | Two-dimensional HyCoSy with contrast tuned imaging technology and a second-generation contrast media for the assessment of tubal patency in an infertility program. | Q51680771 |
| | Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy. | Q52610843 |
| | Differential diagnosis of small solid pancreatic lesions. | Q52852651 |
| | Clinical report: contrast enhancement of tumor perfusion as a guidance for biopsy. | Q52967693 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II. Diagnostic Ultrasound-Guided Interventional Procedures (Short Version). | Q52986814 |
| | Benefit of Contrast-Enhanced Ultrasound (CEUS) in the Follow-Up Care of Patients with Colon Cancer: A Prospective Multicenter Study. | Q52989076 |
| | EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. | Q53112216 |
| | Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. | Q53186158 |
| | New technology--combined use of 3D contrast enhanced endoscopic ultrasound techniques. | Q53219797 |
| | Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors | Q53276035 |
| | Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. | Q53393569 |
| | Percutaneous transhepatic cholangiography and drainage using extravascular contrast enhanced ultrasound. | Q53509540 |
| | The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. | Q53523227 |
| | Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. | Q53576054 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part V - EUS-Guided Therapeutic Interventions (short version). | Q54650831 |
| | EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part IV - EUS-guided interventions: General Aspects and EUS-guided Sampling (Short Version). | Q54758600 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | contrast-enhanced ultrasound | Q500458 |
| P304 | page(s) | E2-E15 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Ultrasound international open | Q27727393 |
| P1476 | title | How to perform Contrast-Enhanced Ultrasound (CEUS). | |
| P478 | volume | 4 | |